Web Desc
Novel Therapeutic Approaches to Tuberculosis
Organizer(s): Christopher M. Sassetti and Thomas G. Evans
Date: March 30 - April 04, 2014
Location: Keystone Resort, Keystone, CO, USA
Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation
For important information on the coronavirus, please click here
Summary of Meeting:
Despite more than a century of research, tuberculosis kills millions every year. The reasons we are unable to control this disease are well documented; the lack of an effective vaccine, inefficient chemotherapy, and an inability to predict who is at risk of disease. Traditional approaches to antibacterial and vaccine development have produced only incremental improvements in TB therapy, and have had little effect on transmission in the developing world. This symposium will explore novel strategies to treat this disease, either through direct antimicrobial interventions or the manipulation of host immunity. The sessions will explore three topical areas: • The mechanisms underlying the inflammatory response to M. tuberculosis, and novel strategies to ameliorate disease through the manipulation of this response. • New approaches to accelerate TB chemotherapy, concentrating on genetic/chemical synergies, specific targeting of persistent bacterial populations, and host-directed antimicrobial therapies. • Immunotherapy for both latent and active disease, with an emphasis on cytokine modulation and therapeutic vaccines. This symposium will assemble a diverse group of scientists specializing in immunology, bacteriology, cell biology, and therapeutic development. To ensure that insights from basic science are discussed in the context of practical therapeutic solutions, attendees will be drawn from both academic and industrial institutions. A particular emphasis will be placed on lessons gleaned from other systems, such as cancer, acute inflammation, and viral infections, which could be applied to tuberculosis. This diversity of background and approach will encourage the development of truly novel approaches to treat this devastating disease.
Global Health Travel Award Deadline: October 29 2013
Scholarship Deadline: December 3 2013
Discounted Abstract Deadline: December 3 2013
Abstract Deadline: January 7 2014
Discounted Registration Deadline: January 29 2014
Abstacts when book is in proofing process


Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Bill & Melinda Gates Foundation
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Transgene SA
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI109839-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Sunday, March 30 | 4:00PM - 8:00PM
Arrival and Registration
Room: Longs Peak Foyer


Monday, March 31 | 7:00AM - 8:00AM
Breakfast
Room: Red Cloud/Shavano/Torreys


Monday, March 31 | 8:00AM - 9:00AM
Keynote Address
Room: Grays Peak

Speaker 1 of 1
Charles N. Serhan, Brigham and Women's Hospital, USA
Regulation of Acute Inflammation and Resolution:
Lessons from Novel Lipid Mediators


Monday, March 31 | 9:00AM - 11:45AM
Inflammation: Balance between Bacterial Control and Immunopa
thology

Room: Grays Peak

Speaker 1 of 7
* Babak Javid, Tsinghua University School of Medicine, China

Monday, March 31 | 9:00AM - 11:45AM
Inflammation: Balance between Bacterial Control and Immunopa
thology

Room: Grays Peak

Speaker 2 of 7
David M. Tobin, Duke University School of Medicine, USA
Modulation of Eicosanoids and Angiogenesis as Host-Directed Therapies for Mycobacterial Infections

Monday, March 31 | 9:00AM - 11:45AM
Inflammation: Balance between Bacterial Control and Immunopa
thology

Room: Grays Peak

Speaker 3 of 7
Bibhuti B. Mishra, University of Massachusetts Medical School, USA
Short Talk: 12-Lipoxygenase Controls Neutrophil Influx to the Lungs and Regulates Tolerance to Tuberculosis Disease

Monday, March 31 | 9:00AM - 11:45AM
Inflammation: Balance between Bacterial Control and Immunopa
thology

Room: Grays Peak

Speaker 4 of 7
Andrea M. Cooper, University of Leicester, UK
The Impact of Bacterial Dose on the Development of Early Cellular Responses to Mycobacterium tuberculosis Infection and the Consequences for Survival

Monday, March 31 | 9:00AM - 11:45AM
Inflammation: Balance between Bacterial Control and Immunopa
thology

Room: Grays Peak

Speaker 5 of 7
Helen A. Fletcher, London School of Hygiene and Tropical Medicine, UK
Role of Myeloid Signatures in the Prediction of Active Tuberculosis

Monday, March 31 | 9:00AM - 11:45AM
Inflammation: Balance between Bacterial Control and Immunopa
thology

Room: Grays Peak

Speaker 6 of 7
Ajay Grover, Colorado State University, USA
Short Talk: Early Immune Responses Associated with the Severity of Tuberculosis Disease Outcome

Monday, March 31 | 9:00AM - 11:45AM
Inflammation: Balance between Bacterial Control and Immunopa
thology

Room: Grays Peak

Speaker 7 of 7
Janice J. Endsley, University of Texas Medical Branch, USA
Short Talk: Inflammation and Accelerated Mycobacterial Growth in M.tb/HIV-1 Co-Infected Humanized Mice

Monday, March 31 | 9:40AM - 10:00AM
Coffee Break
Room: Longs Peak Foyer


Monday, March 31 | 11:45AM - 1:00PM
Poster Setup
Room: Red Cloud/Shavano/Torreys


Monday, March 31 | 11:45AM - 2:00PM
On Own for Lunch and Recreation


Monday, March 31 | 1:00PM - 10:00PM
Poster Viewing
Room: Red Cloud/Shavano/Torreys


Monday, March 31 | 2:00PM - 4:30PM
Workshop 1: Understanding and Overcoming Resistance
Room: Grays Peak

Speaker 1 of 6
James E. Posey, Centers for Disease Control, USA
The Known Unknowns of Drug Resistance in Mycobacterium tuberculosis

Monday, March 31 | 2:00PM - 4:30PM
Workshop 1: Understanding and Overcoming Resistance
Room: Grays Peak

Speaker 2 of 6
Sarah M. Fortune, Harvard TH Chan School of Public Health, USA
On the Clock: Identifying Drivers of Drug Resistance

Monday, March 31 | 2:00PM - 4:30PM
Workshop 1: Understanding and Overcoming Resistance
Room: Grays Peak

Speaker 3 of 6
* David Alland, Rutgers University, New Jersey Medical School, USA
Exploring the Mycobacterium tuberculosis Resistome: Lessons on the Multiple Pathways to Drug Resistance

Monday, March 31 | 2:00PM - 4:30PM
Workshop 1: Understanding and Overcoming Resistance
Room: Grays Peak

Speaker 4 of 6
William R. Jacobs, Jr., HHMI/Albert Einstein College of Medicine, USA
Visualizing Mycobacterium tuberculosis Persisters to see their Roles Latency and Drug Resistance

Monday, March 31 | 2:00PM - 4:30PM
Workshop 1: Understanding and Overcoming Resistance
Room: Grays Peak

Speaker 5 of 6
Eric Nuermberger, Johns Hopkins University, USA
Short Talk: Studying Resistance Selection in Preclinical Animal Models

Monday, March 31 | 2:00PM - 4:30PM
Workshop 1: Understanding and Overcoming Resistance
Room: Grays Peak

Speaker 6 of 6
Anne Lenaerts, Colorado State University, USA
Short Talk: Spectinamides, A Novel Class of Antituberculosis Agents that also Overcome Native Drug Efflux

Monday, March 31 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Monday, March 31 | 5:00PM - 7:00PM
Strategies to Ameliorate Lung Damage
Room: Grays Peak

Speaker 1 of 6
* Sanjay K. Jain, Johns Hopkins University, USA

Monday, March 31 | 5:00PM - 7:00PM
Strategies to Ameliorate Lung Damage
Room: Grays Peak

Speaker 2 of 6
Paul T. Elkington, University of Southampton, UK
Targeting Matrix Metalloproteinase Activity to Reduce Immunopathology

Monday, March 31 | 5:00PM - 7:00PM
Strategies to Ameliorate Lung Damage
Room: Grays Peak

Speaker 3 of 6
Eric Nuermberger, Johns Hopkins University, USA
Short Talk: Cavitary TB in C3HeB/FeJ Mice

Monday, March 31 | 5:00PM - 7:00PM
Strategies to Ameliorate Lung Damage
Room: Grays Peak

Speaker 4 of 6
Samuel M. Behar, University of Massachusetts Medical School, USA
Tissue-Protective Activities of Anti-Microbial Immune Responses

Monday, March 31 | 5:00PM - 7:00PM
Strategies to Ameliorate Lung Damage
Room: Grays Peak

Speaker 5 of 6
Anca Dorhoi, Friedrich-Loeffler-Institut, Germany
Regulators of Neutrophil-Mediated Tissue Injury

Monday, March 31 | 5:00PM - 7:00PM
Strategies to Ameliorate Lung Damage
Room: Grays Peak

Speaker 6 of 6
Bintou Ahmadou Ahidjo, Johns Hopkins University, USA
Short Talk: Pirfenidone, an Approved Anti-Fibrotic Agent, Alters TB Lung Pathology and Is Detrimental to Multidrug Treatment of TB in Mice

Monday, March 31 | 6:00PM - 8:00PM
Welcome Mixer
Room: Longs Peak Foyer


Monday, March 31 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Red Cloud/Shavano/Torreys


Monday, March 31 | 7:30PM - 10:00PM
Poster Session 1
Room: Red Cloud/Shavano/Torreys


Tuesday, April 01 | 7:00AM - 8:00AM
Breakfast
Room: Red Cloud/Shavano/Torreys


Tuesday, April 01 | 8:00AM - 11:15AM
Novel Antimicrobial Strategies
Room: Grays Peak

Speaker 1 of 7
Philana Ling Lin, University of Pittsburgh, USA
The Fuzzy Logic of Tuberculosis: Reconciling Biology with Disease

Tuesday, April 01 | 8:00AM - 11:15AM
Novel Antimicrobial Strategies
Room: Grays Peak

Speaker 2 of 7
* Christina L. Stallings, Washington University School of Medicine, USA
Genetic and Chemical Approaches to Discovering New Anti-Virulence Strategies

Tuesday, April 01 | 8:00AM - 11:15AM
Novel Antimicrobial Strategies
Room: Grays Peak

Speaker 3 of 7
Lalita Ramakrishnan, University of Cambridge, UK
Targeting Host and in vivo Induced Bacterial Determinants for TB Treatment

Tuesday, April 01 | 8:00AM - 11:15AM
Novel Antimicrobial Strategies
Room: Grays Peak

Speaker 4 of 7
Terry Roemer, Merck, USA
Chemical Genetics, Combination Agents and Antibacterial Lead Finding: A Staphylococcus aureus Case Study

Tuesday, April 01 | 8:00AM - 11:15AM
Novel Antimicrobial Strategies
Room: Grays Peak

Speaker 5 of 7
Donald R. Ronning, University of Nebraska Medical Center, USA
Short Talk: Understanding Trehalose Biosynthesis, Utilization and Salvage as a Basis for Developing New TB Drugs

Tuesday, April 01 | 8:00AM - 11:15AM
Novel Antimicrobial Strategies
Room: Grays Peak

Speaker 6 of 7
Robert B. Abramovitch, Michigan State University, USA
Short Talk: High-Throughput Screens for Inhibitors of Mycobacterium tuberculosis Two-Component Regulatory Systems

Tuesday, April 01 | 8:00AM - 11:15AM
Novel Antimicrobial Strategies
Room: Grays Peak

Speaker 7 of 7
Pradeep Kumar, Rutgers-ICPH, USA
Short Talk: Pathway-Driven Approach to Antitubercular Drug Discovery

Tuesday, April 01 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer


Tuesday, April 01 | 11:15AM - 1:00PM
Poster Setup
Room: Red Cloud/Shavano/Torreys


Tuesday, April 01 | 11:15AM - 5:00PM
On Own for Lunch and Recreation


Tuesday, April 01 | 1:00PM - 10:00PM
Poster Viewing
Room: Red Cloud/Shavano/Torreys


Tuesday, April 01 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Tuesday, April 01 | 5:00PM - 7:00PM
Host-Directed Antimicrobial Therapies
Room: Grays Peak

Speaker 1 of 6
* Mamodikoe Makhene, NIAID, National Institutes of Health, USA

Tuesday, April 01 | 5:00PM - 7:00PM
Host-Directed Antimicrobial Therapies
Room: Grays Peak

Speaker 2 of 6
Robert J. Wilkinson, University of Cape Town, South Africa
The Interaction between Antimicrobial and Adjunctive Therapies and the Immune Response to Tuberculosis

Tuesday, April 01 | 5:00PM - 7:00PM
Host-Directed Antimicrobial Therapies
Room: Grays Peak

Speaker 3 of 6
William R. Bishai, Johns Hopkins School of Medicine, USA and K-RITH, South Africa, USA
Immunomodulation during Therapy

Tuesday, April 01 | 5:00PM - 7:00PM
Host-Directed Antimicrobial Therapies
Room: Grays Peak

Speaker 4 of 6
Mariëlle C. Haks, Leiden University Medical Center, Netherlands
Short Talk: A Novel High-Content siRNA and Chemical Compound Screening Assay for Host Regulation of Intracellular Bacterial survival

Tuesday, April 01 | 5:00PM - 7:00PM
Host-Directed Antimicrobial Therapies
Room: Grays Peak

Speaker 5 of 6
Daniel Kalman, Emory University, USA
Host-Directed Tyrosine Kinase Inhibitors as Therapeutics for Antibiotic-Resistant TB

Tuesday, April 01 | 5:00PM - 7:00PM
Host-Directed Antimicrobial Therapies
Room: Grays Peak

Speaker 6 of 6
Lauren T. Robertson, Harvard University, USA
Short Talk: Macrophage Lipid Chaperones Mediate Protection from Tuberculosis Pathogenesis

Tuesday, April 01 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Red Cloud/Shavano/Torreys


Tuesday, April 01 | 7:30PM - 10:00PM
Poster Session 2
Room: Red Cloud/Shavano/Torreys


Wednesday, April 02 | 7:00AM - 8:00AM
Breakfast
Room: Red Cloud/Shavano/Torreys


Wednesday, April 02 | 8:00AM - 11:15AM
Targeting Persistent Bacterial Populations
Room: Grays Peak

Speaker 1 of 8
* Bree B. Aldridge, Tufts University, USA

Wednesday, April 02 | 8:00AM - 11:15AM
Targeting Persistent Bacterial Populations
Room: Grays Peak

Speaker 2 of 8
Rodney Dawson, University of Cape Town, South Africa
Toward Treatment Shortening Regimens in Tuberculosis

Wednesday, April 02 | 8:00AM - 11:15AM
Targeting Persistent Bacterial Populations
Room: Grays Peak

Speaker 3 of 8
Tawanda Gumbo, University of Texas Southwestern Medical Center, USA
Accelerating Kill of Tuberculosis Persisters: Interaction of Drug Concentrations and Novel Bacterial Complex Adaptive Systems

Wednesday, April 02 | 8:00AM - 11:15AM
Targeting Persistent Bacterial Populations
Room: Grays Peak

Speaker 4 of 8
Christopher M. Sassetti, University of Massachusetts Medical School, USA
Bacterial Adaptations to the Host Environment

Wednesday, April 02 | 8:00AM - 11:15AM
Targeting Persistent Bacterial Populations
Room: Grays Peak

Speaker 5 of 8
Adrie J. C. Steyn, Africa Health Research Institute & UAB, South Africa
Short Talk: Untargeted Metabolomic Discovery of a Redox Hierarchy in Mycobacteria and Human Tuberculosis

Wednesday, April 02 | 8:00AM - 11:15AM
Targeting Persistent Bacterial Populations
Room: Grays Peak

Speaker 6 of 8
Stewart T. Cole, Institut Pasteur, France
SS18b - a Drug Discovery Tool for Latent Tuberculosis

Wednesday, April 02 | 8:00AM - 11:15AM
Targeting Persistent Bacterial Populations
Room: Grays Peak

Speaker 7 of 8
Thulasi Warrier, Weill Cornell Medical College, USA
Short Talk: Identification of Novel Anti-Mycobacterial Compounds by Screening a Pharmaceutical Company Library Against Non-Replicating M. tuberculosis

Wednesday, April 02 | 8:00AM - 11:15AM
Targeting Persistent Bacterial Populations
Room: Grays Peak

Speaker 8 of 8
Martin Cohen-Gonsaud, CNRS - France, France
Short Talk: Metabolite-Regulated Shutdown of Efflux Pumps is Critical for Mycobacterial Survival in Non-Permissive Growth Conditions

Wednesday, April 02 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer


Wednesday, April 02 | 11:15AM - 1:00PM
Poster Setup
Room: Red Cloud/Shavano/Torreys


Wednesday, April 02 | 11:15AM - 2:00PM
On Own for Lunch and Recreation


Wednesday, April 02 | 1:00PM - 10:00PM
Poster Viewing
Room: Red Cloud/Shavano/Torreys


Wednesday, April 02 | 2:00PM - 4:30PM
Workshop 2: Basic Science: Foundations of the Next Generatio
n of Therapeutics
Room: Grays Peak

Speaker 1 of 7
* Tom H. M. Ottenhoff, Leiden University Medical Center, Netherlands
Short Talk: In situ Genome-Wide Expression Profiling Helps Deciphering New M. tuberculosis Antigens for Vaccine Development

Wednesday, April 02 | 2:00PM - 4:30PM
Workshop 2: Basic Science: Foundations of the Next Generatio
n of Therapeutics
Room: Grays Peak

Speaker 2 of 7
Kees Korbee, Leiden University Medical Center, Netherlands
Identification of Host Signalling Intermediates Regulating Survival of Intracellular Bacteria

Wednesday, April 02 | 2:00PM - 4:30PM
Workshop 2: Basic Science: Foundations of the Next Generatio
n of Therapeutics
Room: Grays Peak

Speaker 3 of 7
Christoph Grundner, Seattle Children's Research Institute, USA
Protein Tyrosine Phosphorylation in Mycobacterium tuberculosis

Wednesday, April 02 | 2:00PM - 4:30PM
Workshop 2: Basic Science: Foundations of the Next Generatio
n of Therapeutics
Room: Grays Peak

Speaker 4 of 7
Daniel L. Barber, NIAID, National Institutes of Health, USA
Control of Mycobacterium tuberculosis Infection by a Subset of Lung Parenchyma Homing CD4 T Cells

Wednesday, April 02 | 2:00PM - 4:30PM
Workshop 2: Basic Science: Foundations of the Next Generatio
n of Therapeutics
Room: Grays Peak

Speaker 5 of 7
Thomas R. Hawn, University of Washington, USA
Variation in Macrophage Responses: Can Genetics Lead to Novel Therapeutics?

Wednesday, April 02 | 2:00PM - 4:30PM
Workshop 2: Basic Science: Foundations of the Next Generatio
n of Therapeutics
Room: Grays Peak

Speaker 6 of 7
Israël Casabon, University of British Columbia, Canada
Cholesterol Catabolism by Mycobacterium tuberculosis: Still Many Unknowns

Wednesday, April 02 | 2:00PM - 4:30PM
Workshop 2: Basic Science: Foundations of the Next Generatio
n of Therapeutics
Room: Grays Peak

Speaker 7 of 7
Marcela Henao-Tamayo, Colorado State University, USA
Short Talk: BCG Vaccination Augments Regulatory T Cell Immunosuppression
during Mycobacterium tuberculosis Infection


Wednesday, April 02 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Wednesday, April 02 | 5:00PM - 7:00PM
Therapy for Latent TB Infection
Room: Grays Peak

Speaker 1 of 6
* Christine F. Sizemore, NIAID, National Institutes of Health, USA

Wednesday, April 02 | 5:00PM - 7:00PM
Therapy for Latent TB Infection
Room: Grays Peak

Speaker 2 of 6
David M. Margolis, University of North Carolina at Chapel Hill, USA
Eradication of Latent Pathogens: Lessons from HIV

Wednesday, April 02 | 5:00PM - 7:00PM
Therapy for Latent TB Infection
Room: Grays Peak

Speaker 3 of 6
Peter L. Andersen, Statens Serum Institut, Denmark
Progress toward a Vaccine Targeting LTBI

Wednesday, April 02 | 5:00PM - 7:00PM
Therapy for Latent TB Infection
Room: Grays Peak

Speaker 4 of 6
Gavin J. Churchyard, Aurum Institute NPC, South Africa
Community/Population-Based Interventions for LTBI

Wednesday, April 02 | 5:00PM - 7:00PM
Therapy for Latent TB Infection
Room: Grays Peak

Speaker 5 of 6
Parul Mehrotra, International Centre for Genetic Engineering and Biotechnology, India
Short Talk: Pathogenicity of Mycobacterium tuberculosis is Governed by its Ability to Thread through Metabolic Thresholds of the Host Macrophage

Wednesday, April 02 | 5:00PM - 7:00PM
Therapy for Latent TB Infection
Room: Grays Peak

Speaker 6 of 6
Sara Suliman, Brigham and Women's Hospital, USA
Short Talk: Impact of M. tuberculosis Pre-Clearance with Isoniazid (INH) on Innate and Adaptive T-Cell Responses to BCG Revaccination in Latently Infected Adults

Wednesday, April 02 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Red Cloud/Shavano/Torreys


Wednesday, April 02 | 7:30PM - 10:00PM
Poster Session 3
Room: Red Cloud/Shavano/Torreys


Thursday, April 03 | 7:00AM - 8:00AM
Breakfast
Room: Red Cloud/Shavano/Torreys


Thursday, April 03 | 8:00AM - 11:00AM
Immunotherapy for Active Disease
Room: Grays Peak

Speaker 1 of 7
* W. Henry Boom, Case Western Reserve University, USA

Thursday, April 03 | 8:00AM - 11:00AM
Immunotherapy for Active Disease
Room: Grays Peak

Speaker 2 of 7
Robert L. Modlin, University of California, Los Angeles, USA
Immune Networks in Human Tuberculosis

Thursday, April 03 | 8:00AM - 11:00AM
Immunotherapy for Active Disease
Room: Grays Peak

Speaker 3 of 7
Selvakumar Subbian, USA
Changing the Course of TB Pathogenesis and Treatment

Thursday, April 03 | 8:00AM - 11:00AM
Immunotherapy for Active Disease
Room: Grays Peak

Speaker 4 of 7
Steven M. Holland, NIAID, National Institutes of Health, USA
Genetic Determinants of Reactivation

Thursday, April 03 | 8:00AM - 11:00AM
Immunotherapy for Active Disease
Room: Grays Peak

Speaker 5 of 7
Dipendra Kumar Mitra, All India Institute of Medical Sciences - AIIMS, India
Short Talk: Inhibiting PD-1 Pathway Restores M. tuberculosis Specific Effector T Cell Response in Human Tuberculosis

Thursday, April 03 | 8:00AM - 11:00AM
Immunotherapy for Active Disease
Room: Grays Peak

Speaker 6 of 7
Alan Sher, NIAID, National Institutes of Health, USA
Innate Immune Mediators as Targets for Host-Directed Therapy of Tuberculosis

Thursday, April 03 | 8:00AM - 11:00AM
Immunotherapy for Active Disease
Room: Grays Peak

Speaker 7 of 7
Katrin D. Mayer-Barber, NIAID, National Institutes of Health, USA
Short Talk: Interleukin-1 - Type I Interferon Counter-Regulation Reveals Eicosanoids as Targets for Host-Directed Therapy of Tuberculosis

Thursday, April 03 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer


Thursday, April 03 | 11:00AM - 5:00PM
On Own for Lunch and Recreation


Thursday, April 03 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Thursday, April 03 | 5:00PM - 7:00PM
Therapeutic Vaccines
Room: Grays Peak

Speaker 1 of 6
* Warwick J. Britton, Centenary Institute, Australia

Thursday, April 03 | 5:00PM - 7:00PM
Therapeutic Vaccines
Room: Grays Peak

Speaker 2 of 6
Geneviève Inchauspe, Transgène, France
Immune Modulation in Latent and Active Diseases through Vaccination

Thursday, April 03 | 5:00PM - 7:00PM
Therapeutic Vaccines
Room: Grays Peak

Speaker 3 of 6
Rhea N. Coler, Infectious Disease Research Institute, USA
Preclinical and Clinical Testing of a Prophylactic and Therapeutic TB Vaccine

Thursday, April 03 | 5:00PM - 7:00PM
Therapeutic Vaccines
Room: Grays Peak

Speaker 4 of 6
Cláudio Nunes-Alves, University of Massachusetts Medical School, USA
Short Talk: Clonal T Cell Expansions Against Immunodominant Epitopes Are Protective during Tuberculosis

Thursday, April 03 | 5:00PM - 7:00PM
Therapeutic Vaccines
Room: Grays Peak

Speaker 5 of 6
Dominique N. Price, University of New Mexico, USA
Short Talk: Inhaled BCG Immunization: A Vaccination Strategy to Bypass Interference by Environmental Mycobacteria and Increase Protective Efficacy

Thursday, April 03 | 5:00PM - 7:00PM
Therapeutic Vaccines
Room: Grays Peak

Speaker 6 of 6
Thomas Evans, TomegaVax, USA
The Promise of Therapeutic Vaccination

Thursday, April 03 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Red Cloud/Shavano/Torreys


Thursday, April 03 | 8:00PM - 11:00PM
Entertainment
Room: Red Cloud/Shavano/Torreys


Thursday, April 03 | 8:00PM - 11:00PM
Cash Bar
Room: Red Cloud/Shavano/Torreys


Friday, April 04 | 10:23AM - 10:23AM
Departure


*Session Chair
†Invited, not yet responded.